Frank S Lieberman MD
Neurooncology
Professor of Neurology, Neurosurgery and Medicine (Medical Oncology) University of Pittsburgh School of Medicine
Join to View Full Profile
5150 Centre AvePittsburgh, PA 15232
Phone+1 412-692-4724
Fax+1 412-641-1221
Dr. Lieberman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoPost-Doctoral Fellowship, Neuroimmunology & Multiple Sclerosis, 1983 - 1985- University of ChicagoResidency, Neurology, 1980 - 1983
- University of ChicagoInternship, Internal Medicine, 1979 - 1980
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1979
Certifications & Licensure
PA State Medical License 1999 - 2024
NJ State Medical License 1985 - 1991
IL State Medical License 1980 - 1987
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2015-2016
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2015-2016
Clinical Trials
- Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors Start of enrollment: 2001 Oct 09
- Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2004 Nov 01
- Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas Start of enrollment: 2006 Dec 01
Publications & Presentations
PubMed
- 5 citationsA multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma.Patrick Y Wen, Andrea Manzanera, Caroline Duault, Edgar Gonzalez-Kozlova, Lenika Lopez
Neuro-Oncology. 2025-10-01 - 9 citationsA window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma.Veronica Rendo, Eudocia Q Lee, Connor Bossi, Nicholas Khuu, Michelle A Rudek
Science Translational Medicine. 2025-02-19 - Fast Hadamard-Encoded 7T Spectroscopic Imaging of Human Brain.Chan Hong Moon, Frank S Lieberman, Hoby P Hetherington, Jullie W Pan
Tomography. 2025-01-13
Press Mentions
Comprehensive Genetic Profiling Possible for Central Nervous System TumorsFebruary 11th, 2016
Test Rapidly, Accurately Profiles Genetics and Treatment of Brain TumorsFebruary 1st, 2016
Grant Support
- Nabtc Member Institution Grant (Ucsf Project Leader)National Cancer Institute2002–2008
- Phi/Ii Trial Of R115777 In PTS W/Recurrent Malignant GliomaNational Center For Research Resources2005
- PH II TRL Of EMD 121974 Rcurrent Glioblastoma Clin Trial W/Tissue Correlate RESPNational Center For Research Resources2005
- PH I/II Trial OSI-774 PTS W/Recurr Malig Gliomas &Malig Gliomas Post RadiatnNational Center For Research Resources2005
- Phi/Ii ZD1839 In Subj W/Recurr. Malig. Glioma MeningiomasNational Center For Research Resources2004
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
